Ensysce Biosciences ENSC
NASDAQ ENSC
$0.52 +0.02 (+4.29%)
At close: Oct 21, 2026 · 4:00 PM EDT

Ensysce Biosciences (ENSC) Other Non-Current Assets (2020 - 2025)

Updated

Ensysce Biosciences' Other Non-Current Assets came in at $83,332 for Q4 2025, down 67.0% from $252,550 a year earlier and down 34.7% from the prior quarter.

Analysis

Ensysce Biosciences (ENSC) Other Non-Current Assets (2020 - 2025) Analysis & Trends

Going back to Q4 2020, Ensysce Biosciences' Other Non-Current Assets data covers 20 quarters.

  • Other Non-Current Assets has declined in each of the last four years, though with a five-year compound annual growth rate of 85.6% (FY2020 to FY2025).
  • Going back by year, Other Non-Current Assets was $252,550 in FY2024 (-39.8%), $419,217 in FY2023 (-28.4%), $585,883 in FY2022 (-22.4%) and $754,756 in FY2021.
  • The Q4 2025 figure represents the lowest quarterly Other Non-Current Assets since Q4 2020.
  • Year-over-year, Other Non-Current Assets has declined for 15 consecutive quarters, with an average decline of 40.0% over the last eight quarters.
  • Over the past five years, the year-over-year decline in Other Non-Current Assets ranged from 12.8% (Q2 2025) to 67.0% (Q4 2025).
  • Business Quant data shows ENSC's Other Non-Current Assets at $127,551 (Q3 2025), $292,860 (Q2 2025) and $210,883 (Q1 2025) in the three quarters before Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.48 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 14.27 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 10.73 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 19.60 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 5.93 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 12.98 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 4.75 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 9.94 Bn
10 Ensysce Biosciences 1.35 Mn -9.90 Mn - 165,825.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 165,825.00
Sep 30, 2025 127,551.00
Jun 30, 2025 292,860.00
Mar 31, 2025 210,883.00
Dec 31, 2024 252,550.00
Sep 30, 2024 294,217.00
Jun 30, 2024 335,883.00
Mar 31, 2024 377,550.00
Dec 31, 2023 419,217.00
Sep 30, 2023 460,883.00
Jun 30, 2023 502,550.00
Mar 31, 2023 544,217.00
Dec 31, 2022 585,883.00
Sep 30, 2022 627,550.00
Jun 30, 2022 754,242.00
Mar 31, 2022 713,090.00
Dec 31, 2021 754,756.00
Sep 30, 2021 796,423.00
Jun 30, 2021 838,091.00
Dec 31, 2020 3,780.00
API Access

Ensysce Biosciences Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ENSC&period=max&api_key=YOUR_API_KEY